Substrates for peptidase S08.109: KPC2-type peptidase
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| fMRFamide-like neuropeptide 18 | Q9N4V0 | 22-208 | peptide-Arg56+Asp-peptide | P | MS | Phe | Ser | Lys | Arg | Asp | Phe | Asp | Gly | Husson et al., 2006 | ||
| fMRFamide-like neuropeptide 18 | Q9N4V0 | 22-208 | peptide-Lys85+Glu-peptide | P | MS | Val | Gln | Lys | Lys | Glu | Met | Pro | Gly | Husson et al., 2006 | ||
| fMRFamide-like neuropeptide 18 | Q9N4V0 | 22-208 | peptide-Lys103+Ser-peptide | P | MS | Asp | Glu | Lys | Lys | Ser | Val | Pro | Gly | Husson et al., 2006 | ||
| fMRFamide-like neuropeptide 18 | Q9N4V0 | 22-208 | peptide-Arg139+Glu-peptide | P | MS | Met | Asp | Lys | Arg | Glu | Ile | Pro | Gly | Husson et al., 2006 | ||
| fMRFamide-like neuropeptide 18 | Q9N4V0 | 22-208 | peptide-Arg160+Ser-peptide | P | MS | Phe | Asp | Lys | Arg | Ser | Glu | Val | Pro | Husson et al., 2006 | ||
| fMRFamide-like neuropeptide 18 | Q9N4V0 | 22-208 | peptide-Arg172+Asp-peptide | P | MS | Phe | Gly | Lys | Arg | Asp | Val | Pro | Gly | Husson et al., 2006 | ||
| fMRFamide-like neuropeptide 18 | Q9N4V0 | 22-208 | peptide-Arg71+Gly-peptide | P | CS | Phe | Gly | Lys | Arg | Gly | Gly | Val | Trp | Husson et al., 2006 | ||
| fMRFamide-like neuropeptide 18 | Q9N4V0 | 22-208 | peptide-Arg96+Ala-peptide | P | CS | Phe | Gly | Lys | Arg | Ala | Tyr | Phe | Asp | Husson et al., 2006 | ||
| fMRFamide-like neuropeptide 18 | Q9N4V0 | 22-208 | peptide-Arg114+Ser-peptide | P | CS | Phe | Gly | Lys | Arg | Ser | Tyr | Phe | Asp | Husson et al., 2006 | ||
| fMRFamide-like neuropeptide 18 | Q9N4V0 | 22-208 | peptide-Arg150+Asp-peptide | P | CS | Phe | Gly | Lys | Arg | Asp | Tyr | Met | Ala | Husson et al., 2006 | ||
| fMRFamide-like neuropeptide 18 | Q9N4V0 | 22-208 | peptide-Arg183+Ser-peptide | P | CS | Phe | Gly | Lys | Arg | Ser | Asp | Leu | Glu | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 1 | P41855 | 1-175 | peptide-Arg145+Ser-peptide | P | MS | Phe | Gly | Lys | Arg | Ser | Ala | Asp | Pro | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 1 | P41855 | 1-175 | peptide-Arg156+Ser-peptide | P | MS | Arg | Phe | Gly | Arg | Ser | Phe | Asp | Asn | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 1 | P41855 | 1-175 | peptide-Arg100+Ser-peptide | P | MS | Arg | Phe | Gly | Arg | Ser | Gln | Pro | Asn | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 1 | P41855 | 1-175 | peptide-Lys110+Ala-peptide | P | MS | Arg | Phe | Gly | Lys | Ala | Ser | Gly | Asp | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 1 | P41855 | 1-175 | peptide-Arg122+Ser-peptide | P | MS | Arg | Phe | Gly | Arg | Ser | Asp | Pro | Asn | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 1 | P41855 | 1-175 | peptide-Lys132+Ala-peptide | P | MS | Arg | Phe | Gly | Lys | Ala | Ala | Ala | Asp | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 11 | Q21156 | 23-110 | peptide-Arg31+Ala-peptide | P | MS | Ala | Glu | Lys | Arg | Ala | Met | Arg | Asn | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 11 | Q21156 | 23-110 | peptide-Arg42+Ala-peptide | P | MS | Arg | Phe | Gly | Arg | Ala | Ser | Gly | Gly | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 11 | Q21156 | 23-110 | peptide-Arg57+Ser-peptide | P | CS | Phe | Gly | Lys | Arg | Ser | Pro | Leu | Asp | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 11 | Q21156 | 23-110 | peptide-Arg75+Asn-peptide | P | MS | Gln | Gly | Lys | Arg | Asn | Gly | Ala | Pro | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 11 | Q21156 | 23-110 | peptide-Arg87+Ser-peptide | P | CS | Arg | Phe | Gly | Arg | Ser | Gly | Gln | Leu | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 13 | O44185 | 18-160 | peptide-Arg75+Ala-peptide | P | MS | Arg | Phe | Gly | Arg | Ala | Pro | Glu | Ala | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 13 | O44185 | 18-160 | peptide-Arg88+Ala-peptide | P | CS | Phe | Gly | Lys | Arg | Ala | Ala | Asp | Gly | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 13 | O44185 | 18-160 | peptide-Arg113+Ala-peptide | P | MS | Phe | Gly | Lys | Arg | Ala | Ser | Pro | Ser | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 13 | O44185 | 18-160 | peptide-Arg125+Ser-peptide | P | MS | Arg | Phe | Gly | Arg | Ser | Pro | Ser | Ala | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 13 | O44185 | 18-160 | peptide-Arg100+Ala-peptide | P | MS | Arg | Phe | Gly | Arg | Ala | Pro | Glu | Ala | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 13 | O44185 | 18-160 | peptide-Arg137+Ser-peptide | P | CS | Arg | Phe | Gly | Arg | Ser | Ala | Ala | Ala | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 14 | Q9XWV7 | 21-143 | peptide-Arg113+Lys-peptide | P | MS | Phe | Gly | Lys | Arg | Lys | His | Glu | Tyr | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 14 | Q9XWV7 | 21-143 | peptide-Arg123+Lys-peptide | P | CS | Phe | Gly | Lys | Arg | Lys | His | Glu | Tyr | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 14 | Q9XWV7 | 21-143 | peptide-Arg103+Lys-peptide | P | MS | Met | Glu | Lys | Arg | Lys | His | Glu | Tyr | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 14 | Q9XWV7 | 21-143 | peptide-Arg133+Lys-peptide | P | MS | Phe | Gly | Lys | Arg | Lys | His | Glu | Tyr | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 19 | Q9XVX1 | 21-89 | peptide-Arg69+Trp-peptide | P | MS | Met | Glu | Lys | Arg | Trp | Ala | Asn | Gln | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 19 | Q9XVX1 | 21-89 | peptide-Arg79+Ala-peptide | P | MS | Phe | Gly | Lys | Arg | Ala | Ser | Trp | Ala | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 24 | O17058 | 26-69 | peptide-Arg53+Val-peptide | P | MS | Pro | His | Lys | Arg | Val | Pro | Ser | Ala | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 24 | O17058 | 26-69 | peptide-Arg67+Ser-Ile | P | CS | Phe | Gly | Lys | Arg | Ser | Ile | - | - | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 26 | Q8MPY9 | 20-84 | peptide-Arg40+Asn-peptide | P | MS | Leu | Thr | Lys | Arg | Asn | Tyr | Tyr | Glu | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 26 | Q8MPY9 | 20-84 | peptide-Arg50+Glu-peptide | P | MS | Pro | Tyr | Lys | Arg | Glu | Phe | Asn | Ala | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 26 | Q8MPY9 | 20-84 | peptide-Arg64+Gly-peptide | P | MS | Phe | Gly | Lys | Arg | Gly | Gly | Ala | Gly | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 27 | Q18184 | 24-89 | peptide-Arg37+Glu-peptide | P | CS | Met | Glu | Arg | Arg | Glu | Ala | Ser | Ala | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 3 | Q23212 | 23-184 | peptide-Arg114+Ala-peptide | P | MS | Phe | Gly | Lys | Arg | Ala | Ser | Glu | Asp | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 3 | Q23212 | 23-184 | peptide-Arg129+Glu-peptide | P | CS | Phe | Gly | Lys | Arg | Glu | Asp | Gly | Asn | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 3 | Q23212 | 23-184 | peptide-Arg85+Ser-peptide | P | MS | Phe | Gly | Lys | Arg | Ser | Ala | Glu | Pro | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 3 | Q23212 | 23-184 | peptide-Arg98+Asn-peptide | P | MS | Phe | Gly | Lys | Arg | Asn | Pro | Glu | Asn | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 3 | Q23212 | 23-184 | peptide-Arg158+Ser-peptide | P | MS | Phe | Gly | Lys | Arg | Ser | Ala | Asp | Asp | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 3 | Q23212 | 23-184 | peptide-Arg174+Asn-peptide | P | CS | Phe | Gly | Lys | Arg | Asn | Pro | Leu | Gly | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 9 | Q18502 | 20-102 | peptide-Arg65+Lys-peptide | P | MS | Met | Glu | Lys | Arg | Lys | Pro | Ser | Phe | Husson et al., 2006 | ||
| fMRFamide-like neuropeptides 9 | Q18502 | 20-102 | peptide-Arg75+Ser-peptide | P | CS | Phe | Gly | Lys | Arg | Ser | Gly | Tyr | Pro | Husson et al., 2006 | ||
| fMRFamide-like peptide 2a | G5EFN6 | 1-106 | peptide-Arg85+Ser-peptide | P | MS | Phe | Gly | Lys | Arg | Ser | Pro | Arg | Glu | Husson et al., 2006 | ||
| fMRFamide-like peptide 2a | G5EFN6 | 1-106 | peptide-Arg96+Phe-peptide | P | CS | Phe | Gly | Lys | Arg | Phe | Asn | Pro | Leu | Husson et al., 2006 | ||
| fMRFamide-like peptide 7 | G5EEC2 | 1-177 | peptide-Arg78+Ser-peptide | P | MS | Phe | Gly | Lys | Arg | Ser | Pro | Met | Gln | Husson et al., 2006 | ||
| fMRFamide-like peptide 7 | G5EEC2 | 1-177 | peptide-Arg92+Ser-peptide | P | CS | Phe | Gly | Lys | Arg | Ser | Pro | Met | Gln | Husson et al., 2006 | ||
| fMRFamide-like peptide 7 | G5EEC2 | 1-177 | peptide-Arg146+Thr-peptide | P | MS | Leu | Gly | Lys | Arg | Thr | Pro | Met | Gln | Husson et al., 2006 | ||
| fMRFamide-like peptide 7 | G5EEC2 | 1-177 | peptide-Arg160+Ser-peptide | P | CS | Phe | Gly | Lys | Arg | Ser | Met | Glu | Phe | Husson et al., 2006 | ||
| fMRFamide-like peptide 7 | G5EEC2 | 1-177 | peptide-Arg64+Ser-peptide | P | MS | Arg | Phe | Gly | Arg | Ser | Pro | Met | Gln | Husson et al., 2006 | ||
| neuropeptide-like peptide 11 | Q09367 | 1-134 | peptide-Arg58+His-peptide | P | MS | Gln | Ser | Lys | Arg | His | Ile | Ser | Pro | Husson et al., 2006 | ||
| neuropeptide-like peptide 11 | Q09367 | 1-134 | peptide-Arg82+Ser-peptide | P | MS | Ile | Gly | Lys | Arg | Ser | Ala | Pro | Met | Husson et al., 2006 | ||
| neuropeptide-like peptide 11 | Q09367 | 1-134 | peptide-Lys106+Lys-peptide | P | CS | Ala | Gly | Lys | Lys | Lys | Arg | Ser | Pro | Husson et al., 2006 | ||
| neuropeptide-like peptide 11 | Q09367 | 1-134 | peptide-Arg108+Ser-peptide | P | MS | Lys | Lys | Lys | Arg | Ser | Pro | Ala | Ile | Husson et al., 2006 | ||
| neuropeptide-like protein 1 | Q11088 | 20-176 | peptide-Arg25+Met-peptide | P | MS | Leu | Pro | Lys | Arg | Met | Asp | Ala | Asn | Husson et al., 2006 | ||
| neuropeptide-like protein 1 | Q11088 | 20-176 | peptide-Arg38+Ser-peptide | P | CS | Phe | Gly | Lys | Arg | Ser | Val | Ser | Asn | Husson et al., 2006 | ||
| neuropeptide-like protein 1 | Q11088 | 20-176 | peptide-Arg142+Val-peptide | P | MS | Phe | Gly | Lys | Arg | Val | Asn | Leu | Asp | Husson et al., 2006 | ||
| neuropeptide-like protein 1 | Q11088 | 20-176 | peptide-Arg157+Ser-peptide | P | CS | Phe | Gly | Lys | Arg | Ser | Thr | Val | Gly | Husson et al., 2006 | ||
| neuropeptide-like protein 1 | Q11088 | 20-176 | peptide-Arg48+Met-peptide | P | MS | Glu | Ala | Lys | Arg | Met | Asp | Pro | Asn | Husson et al., 2006 | ||
| neuropeptide-like protein 1 | Q11088 | 20-176 | peptide-Arg61+Ser-peptide | P | CS | Phe | Gly | Lys | Arg | Ser | Ala | Glu | Gln | Husson et al., 2006 | ||
| neuropeptide-like protein 1 | Q11088 | 20-176 | peptide-Arg91+Met-peptide | P | MS | Glu | Met | Lys | Arg | Met | Asp | Ala | Asn | Husson et al., 2006 | ||
| neuropeptide-like protein 1 | Q11088 | 20-176 | peptide-Arg104+Ser-peptide | P | CS | Phe | Gly | Lys | Arg | Ser | Asp | Ala | His | Husson et al., 2006 | ||
| neuropeptide-like protein protein 12 | O01970 | 1-80 | peptide-Arg32+Asp-peptide | P | MS | Arg | Gln | Asp | Arg | Asp | Tyr | Arg | Pro | Husson et al., 2006 | ||
| neuropeptide-like protein protein 12 | O01970 | 1-80 | peptide-Arg42+Asp-peptide | P | MS | Phe | Gly | Lys | Arg | Asp | Gly | Tyr | Arg | Husson et al., 2006 | ||
| neuropeptide-like protein protein 12 | O01970 | 1-80 | peptide-Arg53+Asp-peptide | P | CS | Phe | Gly | Lys | Arg | Asp | Tyr | Arg | Pro | Husson et al., 2006 | ||
| neuropeptide-like protein protein 13 | O44540 | 1-137 | peptide-Arg31+Asn-peptide | P | MS | Ser | Ala | Lys | Arg | Asn | Asp | Phe | Ser | Husson et al., 2006 | ||
| neuropeptide-like protein protein 13 | O44540 | 1-137 | peptide-Arg44+Ser-peptide | P | MS | Phe | Gly | Lys | Arg | Ser | Gly | Asn | Thr | Husson et al., 2006 | ||
| neuropeptide-like protein protein 13 | O44540 | 1-137 | peptide-Arg62+Gln-peptide | P | CS | Phe | Gly | Lys | Arg | Gln | Pro | Ser | Tyr | Husson et al., 2006 | ||
| neuropeptide-like protein protein 13 | O44540 | 1-137 | peptide-Arg76+Ser-peptide | P | MS | Phe | Gly | Lys | Arg | Ser | Ala | Pro | Ser | Husson et al., 2006 | ||
| neuropeptide-like protein protein 13 | O44540 | 1-137 | peptide-Arg92+Ser-peptide | P | MS | Phe | Gly | Lys | Arg | Ser | Ser | Ser | Met | Husson et al., 2006 | ||
| neuropeptide-like protein protein 13 | O44540 | 1-137 | peptide-Arg107+Ser-peptide | P | MS | Phe | Gly | Lys | Arg | Ser | Pro | Val | Asp | Husson et al., 2006 | ||
| neuropeptide-like protein protein 13 | O44540 | 1-137 | peptide-Arg122+Ala-peptide | P | MS | Phe | Gly | Lys | Arg | Ala | Glu | Asp | Tyr | Husson et al., 2006 | ||
| neuropeptide-like protein protein 16 | Q22442 | 1-326 | peptide-Arg160+Ser-peptide | P | MS | His | Gln | Lys | Arg | Ser | Val | Asp | Glu | Husson et al., 2006 | ||
| neuropeptide-like protein protein 16 | Q22442 | 1-326 | peptide-Arg182+Ser-peptide | P | CS | His | Gln | Lys | Arg | Ser | Glu | His | Val | Husson et al., 2006 | ||
| neuropeptide-like protein protein 16 | Q22442 | 1-326 | peptide-Lys171+Asn-peptide | P | MS | His | Gln | Lys | Lys | Asn | Ala | Glu | Asp | Husson et al., 2006 | ||
| neuropeptide-like protein protein 20, confirmed by transcript evidence | Q94233 | 1-99 | peptide-Arg66+Ser-peptide | P | MS | Ile | Glu | Ala | Arg | Ser | Gly | Pro | Gln | Husson et al., 2006 | ||
| neuropeptide-like protein protein 20, confirmed by transcript evidence | Q94233 | 1-99 | peptide-Arg84+Arg-peptide | P | CS | Phe | Ala | Lys | Arg | Arg | Ala | Pro | Lys | Husson et al., 2006 | ||
| neuropeptide-like protein protein 7 | Q19569 | 1-121 | peptide-Arg83+Met-peptide | P | MS | Phe | Gly | Lys | Arg | Met | Ile | Leu | Pro | Husson et al., 2006 | ||
| neuropeptide-like protein protein 7 | Q19569 | 1-121 | peptide-Arg101+Gly-peptide | P | CS | Tyr | Asp | Lys | Arg | Gly | Ser | Asp | Ile | Husson et al., 2006 | ||
| neuropeptide-like protein protein 7 | Q19569 | 1-121 | peptide-Arg65+Ser-peptide | P | MS | Ile | Gln | Arg | Arg | Ser | Met | Asp | Asp | Husson et al., 2006 | ||
| pigment dispersing factor 2 | G5EGC3 | 1-89 | peptide-Arg65+Asn-peptide | P | MS | Ile | Asn | Lys | Arg | Asn | Asn | Ala | Glu | Husson et al., 2006 | ||
| protein C01A2.7, confirmed by transcript evidence | Q8T3G1 | 20-101 | peptide-Arg87+Ser-peptide | P | MS | Leu | Tyr | Lys | Arg | Ser | Pro | Ala | Gln | Husson et al., 2006 | ||
| protein C01A2.7, confirmed by transcript evidence | Q8T3G1 | 20-101 | peptide-Arg24+Val-peptide | P | MS | Ser | Asp | Asp | Arg | Val | Leu | Gly | Trp | Husson et al., 2006 | ||
| protein C01A2.7, confirmed by transcript evidence | Q8T3G1 | 20-101 | peptide-Arg38+Ser-peptide | P | CS | Trp | Gly | Lys | Arg | Ser | Val | Gln | Glu | Husson et al., 2006 | ||
| protein C04H5.8, confirmed by transcript evidence | Q7YX92 | 1-71 | peptide-Arg39+Ser-peptide | P | CS | Arg | Leu | Ile | Arg | Ser | Asp | Pro | Ser | Husson et al., 2006 | ||
| protein C33A12.2, confirmed by transcript evidence | Q18356 | 24-71 | peptide-Arg42+Ala-peptide | P | CS | Arg | Phe | Arg | Arg | Ala | Arg | Met | Met | Husson et al., 2006 | ||
| protein D2005.2, confirmed by transcript evidence | Q93409 | 27-172 | peptide-Arg47+Ala-peptide | P | MS | Leu | Val | Lys | Arg | Ala | Phe | Asp | Arg | Husson et al., 2006 | ||
| protein D2005.2, confirmed by transcript evidence | Q93409 | 27-172 | peptide-Arg64+Phe-peptide | P | CS | Gly | Ala | Lys | Arg | Phe | Asp | Arg | Tyr | Husson et al., 2006 | ||
| protein D2005.2, confirmed by transcript evidence | Q93409 | 27-172 | peptide-Lys99+Ala-peptide | P | MS | Pro | Thr | Lys | Lys | Ala | Phe | Asp | Arg | Husson et al., 2006 | ||
| protein D2005.2, confirmed by transcript evidence | Q93409 | 27-172 | peptide-Arg114+Lys-peptide | P | CS | Gly | Ala | Lys | Arg | Lys | Arg | Ser | Phe | Husson et al., 2006 | ||
| protein D2005.2, confirmed by transcript evidence | Q93409 | 27-172 | peptide-Arg116+Ser-peptide | P | MS | Lys | Arg | Lys | Arg | Ser | Phe | Asp | Arg | Husson et al., 2006 | ||
| protein D2005.2, confirmed by transcript evidence | Q93409 | 27-172 | peptide-Arg131+Ser-peptide | P | CS | Leu | Met | Lys | Arg | Ser | Ala | Pro | Glu | Husson et al., 2006 | ||
| protein F33A8.2, confirmed by transcript evidence | O62211 | 1-99 | peptide-Arg70+Ser-peptide | P | MS | Phe | Ala | Lys | Arg | Ser | Pro | Tyr | Arg | Husson et al., 2006 | ||
| protein F33A8.2, confirmed by transcript evidence | O62211 | 1-99 | peptide-Arg81+Ala-peptide | P | CS | Phe | Ala | Lys | Arg | Ala | Ser | Pro | Tyr | Husson et al., 2006 | ||
| protein F39H2.1, confirmed by transcript evidence | Q93702 | 1-93 | peptide-Arg46+Ser-peptide | P | MS | Gln | Val | Lys | Arg | Ser | Pro | Ser | Ala | Husson et al., 2006 | ||
| protein F39H2.1, confirmed by transcript evidence | Q93702 | 1-93 | peptide-Met53+Arg-peptide | P | CS | Ala | Lys | Trp | Met | Arg | Phe | Gly | Lys | Husson et al., 2006 | ||
| protein K04H4.7, confirmed by transcript evidence | Q6LAC9 | 1-96 | peptide-Lys85+Ala-peptide | P | MS | Pro | Ile | Lys | Lys | Ala | Ser | Tyr | Asp | Husson et al., 2006 | ||
| protein W07E11.4, partially confirmed by transcript evidence | Q7YWT6 | 24-71 | peptide-Arg35+Gly-peptide | P | CS | Phe | Gly | Lys | Arg | Gly | Gly | Asn | Ser | Husson et al., 2006 | ||
| protein Y43F8C.1, partially confirmed by transcript evidence | Q9XWP3 | 21-87 | peptide-Arg41+Gly-peptide | P | MS | Gly | Tyr | Gly | Arg | Gly | Gly | Gly | Tyr | Husson et al., 2006 | ||
| protein Y43F8C.2, confirmed by transcript evidence | Q9XWN4 | 1-90 | peptide-Arg46+Gly-peptide | P | MS | Asn | Gly | Asn | Arg | Gly | Gly | Phe | Gly | Husson et al., 2006 | ||
| protein Y43F8C.2, confirmed by transcript evidence | Q9XWN4 | 1-90 | peptide-Arg58+Gly-peptide | P | CS | Phe | Gly | Gly | Arg | Gly | Gly | Asn | Gln | Husson et al., 2006 | ||
| protein Y47D3B.2a, confirmed by transcript evidence | Q9XX02 | 1-164 | peptide-Arg60+Gly-peptide | P | MS | Asp | Tyr | Lys | Arg | Gly | Gly | Ala | Arg | Husson et al., 2006 | ||
| protein Y47D3B.2a, confirmed by transcript evidence | Q9XX02 | 1-164 | peptide-Arg71+Gly-peptide | P | MS | Asp | Glu | Lys | Arg | Gly | Gly | Ala | Arg | Husson et al., 2006 | ||
| protein Y47D3B.2a, confirmed by transcript evidence | Q9XX02 | 1-164 | peptide-Arg97+Gly-peptide | P | CS | Asp | Glu | Lys | Arg | Gly | Gly | Ala | Arg | Husson et al., 2006 | ||
| protein Y47D3B.2a, confirmed by transcript evidence | Q9XX02 | 1-164 | peptide-Arg83+Gly-peptide | P | MS | Glu | Met | Lys | Arg | Gly | Gly | Ala | Arg | Husson et al., 2006 | ||
| protein ZK525.1, confirmed by transcript evidence | O46023 | 1-87 | peptide-Arg58+Arg-peptide | P | MS | Phe | Gly | Lys | Arg | Arg | Gly | Pro | Ser | Husson et al., 2006 | ||
| protein ZK525.1, confirmed by transcript evidence | O46023 | 1-87 | peptide-Arg70+Ser-peptide | P | CS | Phe | Gly | Lys | Arg | Ser | Ser | Phe | His | Husson et al., 2006 | ||
| protein ZK525.1, confirmed by transcript evidence | O46023 | 1-87 | peptide-Lys46+Gly-peptide | P | MS | Tyr | Val | Lys | Lys | Gly | Gly | Pro | Gln | Husson et al., 2006 | ||
| putative uncharacterized protein | Q9N4D8 | 1-123 | peptide-Lys50+Glu-peptide | P | MS | Val | Lys | Gln | Lys | Glu | Gln | Pro | Ala | Husson et al., 2006 | ||
| putative uncharacterized protein | Q9N4D8 | 1-123 | peptide-Arg67+Met-peptide | P | CS | Pro | Gln | Lys | Arg | Met | Val | Ala | Trp | Husson et al., 2006 |
